reports
Melco International Development: 1 director
A director at Melco International Development bought 500,000 shares at 5.524HKD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy...
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that dosing is complete in the second cohort of its Phase 1/2 ArMaDa clinical trial for OCU410 (AAV-hRORA)—a modifier gene therapy candidate being developed for geographic atrophy (GA), an advanced...
Synlab AG: 5 directors
Five Directors at Synlab AG sold 12,104,156 shares at 10.000EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
BTS Group Holding PCL: 1 director
A director at BTS Group Holding PCL bought 5,000,000 shares at 6.000THB and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Want Want China Holdings Ltd: 1 director
A director at Want Want China Holdings Ltd bought 10,990,000 shares at 4.391HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Huize Holding Limited Files 2023 Annual Report on Form 20-F
Huize Holding Limited Files 2023 Annual Report on Form 20-F SHENZHEN, China, April 19, 2024 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize,” the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in China, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (the “SEC”) on April 19, 2024. The annual report can be accessed on the SEC’s we...
The deadline for Valoe’s restructuring programme extended until 14.6.2...
The deadline for Valoe’s restructuring programme extended until 14.6.2024. Valoe has secured financing for the duration of the proceedings and continues to negotiate longer-term financing. Valoe Corporation Stock Exchange Release 19 April 2024 at 14.05 Finnish time The deadline for Valoe’s restructuring programme extended until 14.6.2024. Valoe has secured financing for the duration of the proceedings and continues to negotiate longer-term financing. Valoe Corporation's ("the Company") restructuring proceedings comme...
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP ...
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it has again successfully defended against opposition filed against a key patent for its ADAR-mediated RNA editing platform Axiomer™. The opposition was filed in June 2021 with the European Patent Office (EPO) by a strawman against ProQR’s granted patent , which relates to editing oligonucleotide...
American Express First-Quarter Revenue Increased 11% to $15.8 Billion ...
NEW YORK--(BUSINESS WIRE)-- American Express Company (NYSE: AXP) today reported first-quarter net income of $2.4 billion, or $3.33 per share, compared with net income of $1.8 billion, or $2.40 per share, a year ago. (Millions, except per share amounts, and where indicated) Quarters Ended March 31, Percentage Inc/(Dec) 2024 2023 Billed Business (Billions) FX-adjusted1 $367.0 $345.5 $344.1 6% 7% Total Revenues Net of Interest Expense FX-adjusted1 $15,801 $14,281 $14,230 1...
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024 The Annual General Meeting of Hofseth BioCare ASA for 2024 will be held at the company's premises at Keiser Wilhelms gate 24, 6003 Ålesund, on 10 May 2024 at 13:00 CET. The notice of the Annual General Meeting is attached. For further information, please contact: Jon Olav Ødegård, CEO of Hofseth BioCare ASA Phone: E-mail: About Hofseth BioCare ASA: HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new pharmaceutical drug leads. Research is ongoing to identify the individual e...
Balchem Corporation Announces Quarterly Conference Call for First Quar...
Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024 MONTVALE, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, May 3, 2024, at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. First quarter results will be published prior to the market opening on Friday, May 3, 2024. The press release, and its accompanying financial exhibits, will also...
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3...
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today® - Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) -- Data presented in a platform session at the Annual Meeting of the American Academy of Neurology in Denver, Colorado - NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company develo...
AMCON Distributing Company Acquires Richmond Master Distributors, Inc.
OMAHA, Neb.--(BUSINESS WIRE)-- AMCON Distributing Company (“AMCON”, or the “Company”) (NYSE American: DIT), an Omaha, Nebraska-based Convenience and Foodservice Distributor is pleased to announce it has signed an Asset Purchase Agreement to acquire Richmond Master Distributors, Inc. (“Master Distributors”), of South Bend, Indiana. “We are honored that Patrick Carrico and Scott Carrico have chosen AMCON to continue the legacy and stewardship of this outstanding enterprise, with a long history of innovation, that was founded in 1947,” said Christopher H. Atayan, AMCON’s Chairman and Chief Exec...
Annual Shareholder Meeting of Comet Holding AG approves all agenda ite...
Comet Holding AG / Key word(s): AGMEGM Annual Shareholder Meeting of Comet Holding AG approves all agenda items 19.04.2024 / 12:49 CET/CEST A total of 186 shareholders representing around 77.89% of the voting rights were present at the 75th Annual Shareholder Meeting of Comet Holding AG in Berne. They approved all the agenda items proposed by the Board of Directors (BoD). Reports, separate and consolidated financial statements, dividend The Annual Shareholder Meeting approved the 2023 management report, the separate and consolidated financial statements of Comet Holding A...
Ordentliche Generalversammlung der Comet Holding AG stimmt allen Trakt...
Comet Holding AG / Schlagwort(e): Generalversammlung Ordentliche Generalversammlung der Comet Holding AG stimmt allen Traktanden zu 19.04.2024 / 12:49 CET/CEST An der 75. ordentlichen Generalversammlung (GV) der Comet Holding AG in Bern waren insgesamt 186 Aktionärinnen und Aktionäre anwesend, die rund 77.89% der Stimmrechte vertraten. Diese stimmten allen vom Verwaltungsrat (VR) vorgeschlagenen Traktanden zu. Berichte, Jahres- und Konzernrechnung, Dividende Die GV genehmigte den Lagebericht 2023, die Jahres- und Konzernrechnung der Comet Holding AG, den Bericht über nicht...
Volvo AB: 1 director
A director at Volvo AB bought 2,000,000 shares at 288.141SEK and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
ADDvise Group AB: 2 directors
A director at ADDvise Group AB bought 15,000 shares at 7.300SEK and the significance rating of the trade was 36/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
SLB Announces First-Quarter 2024 Results, Targeting to Return $7 Billi...
KUALA LUMPUR, Malaysia--(BUSINESS WIRE)-- SLB (NYSE: SLB) today announced results for the first-quarter 2024. This press release features multimedia. View the full release here: The exterior of the SLB headquarters in Houston, Texas (Photo: Business Wire) First-Quarter Results (Stated in millions, except per share amounts) Three Months Ended Change Mar. 31,2024 Dec. 31,2023 Mar. 31,2023 Sequential Year-on-year Revenue $8,707 $8,990 $7,736 -3% 13% Income before taxes - GAAP basis $1,357 $1,433 $1,161 ...
Mandiri Herindo Adiperkasa Tbk PT: 1 director
A director at Mandiri Herindo Adiperkasa Tbk PT bought 20,000,000 shares at 206.000IDR and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.